Tudor Investment Corp’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-48,874
| Closed | -$739K | – | 3020 |
|
|
2022
Q3 | $739K | Buy |
+48,874
| New | +$568K | 0.02% | 1135 |
|
|
2022
Q2 | – | Sell |
-84,335
| Closed | -$767K | – | 2641 |
|
|
2022
Q1 | $767K | Buy |
84,335
+32,736
| +63% | +$252K | 0.02% | 1038 |
|
|
2021
Q4 | $362K | Sell |
51,599
-17,892
| -26% | -$187K | 0.01% | 1703 |
|
|
2021
Q3 | $792K | Buy |
+69,491
| New | +$1.02M | 0.01% | 1326 |
|
|
2021
Q2 | – | Sell |
-37,989
| Closed | -$679K | – | 2100 |
|
|
2021
Q1 | $679K | Buy |
+37,989
| New | +$656K | 0.01% | 1020 |
|
|
2020
Q3 | – | Sell |
-14,977
| Closed | -$221K | – | 1614 |
|
|
2020
Q2 | $221K | Buy |
14,977
+4,210
| +39% | +$62.3K | 0.01% | 991 |
|
|
2020
Q1 | $145K | Buy |
+10,767
| New | +$204K | 0.01% | 885 |
|
|
2019
Q4 | – | Sell |
-31,049
| Closed | -$597K | – | 1442 |
|
|
2019
Q3 | $597K | Buy |
31,049
+14,305
| +85% | +$328K | 0.02% | 659 |
|
|
2019
Q2 | $495K | Buy |
+16,744
| New | +$645K | 0.01% | 715 |
|
|
2017
Q4 | – | Sell |
-11,010
| Closed | -$535K | – | 1342 |
|
|
2017
Q3 | $535K | Buy |
11,010
+1,449
| +15% | +$79.1K | 0.01% | 619 |
|
|
2017
Q2 | $502K | Buy |
+9,561
| New | +$445K | 0.02% | 572 |
|
|
2016
Q4 | – | Sell |
-16,990
| Closed | -$641K | – | 1668 |
|
|
2016
Q3 | $641K | Buy |
+16,990
| New | +$375K | 0.02% | 609 |
|
Tudor Investment Corp's AERI Position: Q4 2022 in Review
Tudor Investment Corp sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 48,874 shares — an estimated $739K sold.
Tudor Investment Corp first reported a position in AERI in Q3 2016 and held it in 12 quarters. The position peaked at $792K in Q3 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Tudor Investment Corp reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Tudor Investment Corp sold 48,874 Aerie Pharmaceuticals shares in Q4 2022, an estimated $739K.
- Tudor Investment Corp first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 12 quarters.
- Tudor Investment Corp's Aerie Pharmaceuticals position peaked at $792K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.